期刊
JOURNAL OF CONTROLLED RELEASE
卷 354, 期 -, 页码 294-304出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2023.01.020
关键词
Atherosclerosis; Micelles; Low-molecular-weight heparin; Unsaturated fatty acid; P-selectin
The researchers designed a low molecular weight heparin-unsaturated fatty acid conjugate (LMWH-uFA) that acted as an antiatherosclerotic agent and a nanocarrier. This conjugate could regulate blood lipids and inhibit inflammation, leading to better therapeutic effects. In an atherosclerosis mouse model, the drug significantly reduced plaque area and showed promising curative effects.
Atherosclerosis is a chronic disease initiated by lipid-mediated vascular inflammation. From the perspective of conventional treatment, it is difficult to achieve good therapeutic effects via regulation of a single lipid or anti-inflammatory effects. Herein, we designed an amphiphilic low molecular weight heparin-unsaturated fatty acid conjugate (LMWH-uFA) that acted as both an antiatherosclerotic agent and a nanocarrier with self-delivery properties. Structurally, LMWH-uFA self-assembled to form micelles with LMWH as the shell and uFA as the core, without any additives, which guaranteed their biosafety. Functionally, the hydrophilic segment, LMWH, prevented monocyte adhesion to inhibit early vascular inflammation, and the hydrophobic segment, uFA, could participate in the regulation of blood lipids. The anti-inflammatory drug rapamycin (RAP) was encapsulated in the micellar core, which improved its water solubility, and cooperated with LMWH to achieve targeted blockade of the vascular inflammation cascade at P-selectin. The three treatment modules, LMWH, uFA and RAP, were integrated into one system for different therapeutic targets in anticipation of better efficacy. In an atherosclerosis mouse model, RAP-loaded NPs significantly reduced the plaque area and showed satisfactory curative effects, which were related to the targeting of lipid regulation and inflammation. Thus, these modular micellar nano-particles offer a promising approach for the clinical treatment of atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据